Description
Etoxisclerol (Polidocanol) 3% Solution for Injections 60 mg/2 ml – Pack of 5
Composition
Active Ingredient: Polidocanol 3%
Other Ingredients: Water for injections
Mechanism of Action
Etoxisclerol (polidocanol) 3% solution for injections acts as a sclerosing agent by inducing endothelial damage in the treated veins. This leads to the closure of the veins, thereby improving both the cosmetic appearance and symptoms associated with varicose veins and spider veins.
Pharmacological Properties
The pharmacological properties of polidocanol include its ability to disrupt the endothelial lining of veins, resulting in their closure. It is well-tolerated and has been proven effective in the treatment of varicose veins.
Indications for Use
Etoxisclerol (polidocanol) 3% solution for injections is indicated for the treatment of varicose veins and spider veins. It is particularly beneficial in cases where conservative management has not provided adequate relief.
Contraindications
Do not use Etoxisclerol (polidocanol) 3% solution for injections if:
- You are allergic to polidocanol or any other components of the product.
- You have a history of blood clotting disorders.
- You are pregnant or breastfeeding.
Side Effects
Common side effects of Etoxisclerol (polidocanol) 3% solution for injections may include temporary discomfort at the injection site, mild bruising, or skin discoloration. Serious side effects are rare but may include allergic reactions or deep vein thrombosis.
Usage Instructions
Dosage: The dosage of Etoxisclerol should be determined by a healthcare professional based on individual patient needs. Typically, the dosage is calculated according to the size and number of varicose veins to be treated.
Method: Etoxisclerol is for injection use only and should be administered by a qualified healthcare provider experienced in the treatment of varicose veins. The injection technique and frequency will vary depending on the extent of the venous insufficiency.
Benefits Compared to Analogues
Etoxisclerol offers advantages over traditional surgical interventions for varicose veins, such as reduced invasiveness, minimal downtime, and excellent cosmetic outcomes. Compared to other sclerosing agents, Etoxisclerol has demonstrated a lower risk of adverse events and improved patient satisfaction rates.
Suitable Patient Groups
Etoxisclerol can be safely used in a wide range of patient populations, including adults of all ages. However, special caution should be exercised when considering treatment in pregnant or breastfeeding individuals, as well as those with a history of coagulation disorders.
Storage and Shelf Life
Store Etoxisclerol (polidocanol) 3% solution for injections in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the product if it has expired. Once opened, discard any unused portion of the solution.
Packaging Description
Etoxisclerol is supplied in packs containing 5 vials of 2 ml each, with a concentration of 60 mg of polidocanol per 2 ml solution. The packaging is designed to maintain the sterility and integrity of the product until use.
Clinical Evidence and Proven Effectiveness
Etoxisclerol (polidocanol) has been the subject of numerous clinical studies evaluating its efficacy in the treatment of varicose veins. Results have consistently shown that polidocanol injections lead to the closure of varicose veins, resulting in symptom improvement and high patient satisfaction rates.
